These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37770979)

  • 1. Therapeutic targeting of the TPX2/TTK network in colorectal cancer.
    Shaath H; Vishnubalaji R; Elango R; Velayutham D; Jithesh PV; Alajez NM
    Cell Commun Signal; 2023 Sep; 21(1):265. PubMed ID: 37770979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CWH43 Is a Novel Tumor Suppressor Gene with Negative Regulation of TTK in Colorectal Cancer.
    Lee CC; Tsai KY; Lee AW; Wei PL; Huang CY; Batzorig U; Chang YJ
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AURKA/TPX2 axis drives colon tumorigenesis cooperatively with MYC.
    Takahashi Y; Sheridan P; Niida A; Sawada G; Uchi R; Mizuno H; Kurashige J; Sugimachi K; Sasaki S; Shimada Y; Hase K; Kusunoki M; Kudo S; Watanabe M; Yamada K; Sugihara K; Yamamoto H; Suzuki A; Doki Y; Miyano S; Mori M; Mimori K
    Ann Oncol; 2015 May; 26(5):935-942. PubMed ID: 25632068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
    Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
    [No Abstract]   [Full Text] [Related]  

  • 5. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
    Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
    Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression.
    Sillars-Hardebol AH; Carvalho B; Tijssen M; Beliën JA; de Wit M; Delis-van Diemen PM; Pontén F; van de Wiel MA; Fijneman RJ; Meijer GA
    Gut; 2012 Nov; 61(11):1568-75. PubMed ID: 22207630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular subtyping and functional validation of TTK, TPX2, UBE2C, and LRP8 in sensitivity of TNBC to paclitaxel.
    Elango R; Vishnubalaji R; Shaath H; Alajez NM
    Mol Ther Methods Clin Dev; 2021 Mar; 20():601-614. PubMed ID: 33665229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
    Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-485-3p suppresses colorectal cancer via targeting TPX2.
    Taherdangkoo K; Kazemi Nezhad SR; Hajjari MR; Tahmasebi Birgani M
    Bratisl Lek Listy; 2020; 121(4):302-307. PubMed ID: 32356447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer.
    Gomes-Filho SM; Dos Santos EO; Bertoldi ERM; Scalabrini LC; Heidrich V; Dazzani B; Levantini E; Reis EM; Bassères DS
    Cell Oncol (Dordr); 2020 Jun; 43(3):445-460. PubMed ID: 32193808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
    Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
    J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cell cycle-related genes RHAMM, AURKA, TPX2, PLK1, and PLK4 are associated with the poor prognosis of breast cancer patients.
    Kahl I; Mense J; Finke C; Boller AL; Lorber C; Győrffy B; Greve B; Götte M; Espinoza-Sánchez NA
    J Cell Biochem; 2022 Mar; 123(3):581-600. PubMed ID: 35014077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
    Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
    Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of TPX2-related ceRNA network as prognostic biomarkers in lung adenocarcinoma.
    Huo C; Zhang MY; Li R; Zhou XJ; Liu TT; Li JP; Liu X; Qu YQ
    Int J Med Sci; 2020; 17(16):2427-2439. PubMed ID: 33029085
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity.
    Grover A; Singh R; Shandilya A; Priyandoko D; Agrawal V; Bisaria VS; Wadhwa R; Kaul SC; Sundar D
    PLoS One; 2012; 7(1):e30890. PubMed ID: 22303466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioinformatics and experimental validation of an AURKA/TPX2 axis as a potential target in esophageal squamous cell carcinoma.
    Du R; Li K; Zhou Z; Huang Y; Guo K; Zhang H; Chen Z; Zhao X; Han L; Bian H
    Oncol Rep; 2023 Jun; 49(6):. PubMed ID: 37083097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TPX2 promotes cell proliferation and migration via PLK1 in OC.
    Ma S; Rong X; Gao F; Yang Y; Wei L
    Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.